Dolby Laboratories (NYSE: DLB) reported Q4 EPS of $0.81, $0.36 better than the analyst estimate of $0.45. Revenue for the quarter came in at $305 million versus the consensus estimate of $307.94 million.

GUIDANCE:

Dolby Laboratories sees Q1 2025 EPS of $0.96-$1.11, versus the consensus of $1.09. Dolby Laboratories sees Q1 2025 revenue of $330-360 million, versus the consensus of $338 million.

Licensing revenue is estimated to range from $305 million to $335 million.
Gross margins are anticipated to be approximately 87% on a GAAP basis and approximately 90% on a non-GAAP basis.
Operating expenses are anticipated to range from $230 million to $240 million on a GAAP basis and from $190 million to $200 million on a non-GAAP basis.
Effective tax rate is anticipated to be around 20.5% on a GAAP basis and around 18.5% on a non-GAAP basis.

For earnings history and earnings-related data on Dolby Laboratories (DLB) click here.